Ipilimumab vs Polymyxin B Sulfate
Ipilimumab vs Polymyxin B Sulfate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Polymyxin B Sulfate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Polymyxin B Sulfate — Protein.